NCT04274465View on ClinicalTrials.gov

Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia

CompletedOBSERVATIONAL

Enrollment

145

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

June 26, 2024

Study Completion Date

July 15, 2024

Conditions

Cervix LesionCervical Cancer

Interventions

DIAGNOSTIC_TEST

digital PCR (dPCR) assay

It is a highly sensitive and specific droplet digital PCR assay for absolute quantification of circulating tumor HPV DNA for the most prevalent HPV types that will determine if a woman has cHPVDNA

Trial Locations (1)

27599

Tuvara Jenene King, Chapel Hill

All Listed Sponsors

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT04274465 - Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter